Results 1 to 10 of about 8,001 (174)

Long-term efficacy of neural circuit blockade for treating blepharospasm: a retrospective case series study [PDF]

open access: yesFrontiers in Neurology
BackgroundBlepharospasm is a common symptom of Meige syndrome and often leads to functional blindness. Although current treatment options, such as oral medications, botulinum toxin injections, resection of periocular muscles, and deep brain stimulation ...
Gang Liu   +17 more
doaj   +2 more sources

Neuropathic Corneal Pain and Blepharospasm: A Case Series [PDF]

open access: yesDiagnostics
Background and Clinical Significanc: Neuropathic corneal pain is a debilitating condition characterized by ocular pain disproportionate to clinical signs, often resulting from peripheral and central sensitization of the corneal somatosensory pathway ...
Zhang Zhe Thia   +6 more
doaj   +2 more sources

Abnormal inter-hemispheric functional cooperation in blepharospasm [PDF]

open access: yesFrontiers in Neurology
BackgroundBlepharospasm, characterized by involuntary contractions of the orbicularis oculi muscles, significantly impairs the quality of life. Its pathophysiology remains unclear.
Jian-Ping Liu   +12 more
doaj   +2 more sources

Real-World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9-Year Nationwide Analysis in France. [PDF]

open access: yesMov Disord Clin Pract
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Simonetta-Moreau M   +3 more
europepmc   +2 more sources

Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm [PDF]

open access: yesJournal of Movement Disorders, 2021
Objective To assess the impact of periocular surgery, other than orbicularis stripping, on the severity and frequency of blepharospasm symptoms. Methods Consecutive patients with benign essential blepharospasm (BEB) who underwent eyelid/eyebrow surgery ...
Hannah Mary Timlin   +2 more
doaj   +1 more source

Postural stability in blepharospasm: the effects of dual-tasking and botulinum toxin therapy

open access: yesBMJ Neurology Open, 2023
Background Blepharospasm is a focal dystonia that presents as involuntary, intermittent, continuous contractions of the eyelids. Abnormal eyelid contractions in blepharospasm are expected to cause balance problems, but there is no clear information ...
Mehmet Balal   +3 more
doaj   +1 more source

Quantitative evaluation of blinking in blepharospasm using electrooculogram-integrated smart eyeglasses

open access: yesScientific Reports, 2023
Smart eyeglasses with an integrated electrooculogram (EOG) device (JINS MEME ES_R®, JINS Inc.) were evaluated as a quantitative diagnostic tool for blepharospasm.
Ayano Yoshimura   +6 more
doaj   +1 more source

Video analysis of patients with blepharospasm and lower face dystonias

open access: yesDystonia, 2023
Background: Blepharospasm (BSP) is a focal dystonia. There is a lack of standardization in the length of time necessary to get a measure of BSP severity for rating scales.Objectives: 1) Determine the difference between evaluating the number of eye ...
Mahdieh Hosseini   +4 more
doaj   +1 more source

Evaluation of Scheimpflug imaging parameters in blepharospasm and normal eyes

open access: yesBMC Ophthalmology, 2018
Background To investigate changes in corneal elevation, pachymetry, and keratometry in discriminating between normal and blepharospasm eyes, as measured by the Pentacam rotating Scheimpflug camera. Methods This was a prospective, cross-sectional study. A
Huina Zhang   +3 more
doaj   +1 more source

Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series

open access: yesJournal of Medical Case Reports, 2022
Background Oxymetazoline hydrochloride ophthalmic solution (0.1%) is a medication used to treat blepharoptosis. Patients who suffer from blepharoptosis have low-lying eyelids that can hinder their vision.
Jonathan Sung   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy